Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Equity (2019 - 2025)

10x Genomics' Return on Equity history spans 7 years, with the latest figure at 0.06% for Q4 2025.

  • For Q4 2025, Return on Equity rose 20.0% year-over-year to 0.06%; the TTM value through Dec 2025 reached 0.06%, up 20.0%, while the annual FY2025 figure was 0.06%, 19.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.06% at 10x Genomics, up from 0.1% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.06% in Q4 2025 and bottomed at 0.71% in Q1 2021.
  • The 5-year median for Return on Equity is 0.22% (2025), against an average of 0.27%.
  • The largest YoY upside for Return on Equity was 62bps in 2021 against a maximum downside of -60bps in 2021.
  • A 5-year view of Return on Equity shows it stood at 0.07% in 2021, then crashed by -192bps to 0.21% in 2022, then tumbled by -64bps to 0.34% in 2023, then increased by 26bps to 0.25% in 2024, then skyrocketed by 78bps to 0.06% in 2025.
  • Per Business Quant, the three most recent readings for TXG's Return on Equity are 0.06% (Q4 2025), 0.1% (Q3 2025), and 0.11% (Q2 2025).